SANTA CLARA, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...

SANTA CLARA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...

Shockwave C2+ Catheter Expands Utility of IVL in Calcified Coronary Arteries Shockwave C2+ is commercially available for the treatment of de novo coronary artery disease in Europe and select other ...

A detailed agenda for all Shockwave Medical symposia and featured presentations can be found here. While under clinical investigation in the COSIRA-II trial (U.S. and Canada), the Reducer is CE-marked ...

Elliot Hospital has begun offering two new technologies and procedures designed to help patients fight coronary artery disease, the most common type of heart disease. The hospital offers Shockwave IVL ...

Add Yahoo as a preferred source to see more of our stories on Google. With Shockwave, J&J gained a fast-growing treatment for coronary artery disease, which is the most common form of heart disease.

Johnson & Johnson has agreed to acquire Shockwave Medical for approximately $13.1 billion, the companies announced Friday morning. The deal values Shockwave at $335 per share. J&J said in a statement ...

SANTA CLARA, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...